- Trials with a EudraCT protocol (7)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
7 result(s) found for: Fever of Unknown Origin.
Displaying page 1 of 1.
EudraCT Number: 2007-005823-14 | Sponsor Protocol Number: I07005 | Start Date*: 2008-04-03 | ||||||||||||||||
Sponsor Name:CHU de LIMOGES | ||||||||||||||||||
Full Title: Impact de la TEP dans la stratégie diagnostique des fièvres d'origine indéterminée ou des syndromes inflammatoires nus chez l'adulte immunocompétent. | ||||||||||||||||||
Medical condition: Les fièvres d'origine indéterminée ou les syndromes inflammatoires nus. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2004-003745-40 | Sponsor Protocol Number: GS-IT-131-0151 | Start Date*: 2005-02-07 | |||||||||||
Sponsor Name:GILEAD SCIENCES S.R.L. | |||||||||||||
Full Title: Phase II pilot study on safety of administration of 3mg/kg/day three times a week until day 22 (21 days after transplantation day) and 7 mg/kg weekly from day 29 to the end of treatment ( day 50-8t... | |||||||||||||
Medical condition: Fungal Infection High risk patients undergoing allogeneic stem-cell transplantation. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-000103-16 | Sponsor Protocol Number: RC13_0008 | Start Date*: 2013-06-21 | ||||||||||||||||
Sponsor Name:CHU de Nantes | ||||||||||||||||||
Full Title: Antifungal prophylaxis with Micafungin after cord blood allogeneic stem cell transplantation. | ||||||||||||||||||
Medical condition: Adult patients receiving allo-Stem Cell Transplantation using Cord Blood as source of stem cells | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-001546-25 | Sponsor Protocol Number: NL48960.029.14 | Start Date*: 2015-01-06 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:VU University Medical Center | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Short versus extended antibiotic treatment with a carbapenem for high-risk febrile neutropenia in hematology patients with Fever of Unknown Origin: a randomized multicenter open-label non-inferiori... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Febrile neutropenia | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: NL (Completed) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-001506-16 | Sponsor Protocol Number: IB 2005-33 | Start Date*: 2008-07-07 | |||||||||||
Sponsor Name:Institut Bergonié | |||||||||||||
Full Title: Diffuse large B cell non-hodgkin's lymphoma in the vulnerable/frail elderly. A multicentrix randomized phase II trial with emphasis on geritaric assesment and quality of life. | |||||||||||||
Medical condition: Vulnerable/Frail elderly patients older than 70 with diffuse large B-cell lymphoma stage II, III, or IV | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001758-14 | Sponsor Protocol Number: 201677 | Start Date*: 2015-12-18 | |||||||||||
Sponsor Name:GlaxoSmithKline Research and Development Limited | |||||||||||||
Full Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Sirukumab in the Treatment of Patients with Giant Cell Arteritis | |||||||||||||
Medical condition: Giant Cell Arteritis (GCA) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) ES (Prematurely Ended) NL (Prematurely Ended) BG (Prematurely Ended) HU (Prematurely Ended) BE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-003774-16 | Sponsor Protocol Number: EIFFEL | Start Date*: 2016-06-07 |
Sponsor Name:A.R.T.I.C. (Association pour la Recherche de Thérapeutiques Innovantes en Cancérologie ) | ||
Full Title: Phase I/II dose-finding, safety and efficacy study of radium-223 dichloride (XOFIGO®) in renal cell carcinoma patients with bone metastases | ||
Medical condition: Renal cell carcinoma patients with bone metastases, with or without visceral metastases. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.